Choosing an SGLT-2 Inhibitor for a Patient With Type 2 Diabetes: Which Agent (if Any) Is Best?

摘要

The armamentarium of medications for the treatment of type 2 diabetes mellitus (T2DM) has increased substantially over the past 5 to 10 years, most recently with oral medications such as sodium-glucose cotransporter 2 (SGLT-2) inhibitors.